BRIEF-Apricus Biosciences Says Co Received A Nasdaq Staff Deficiency Letter
April 16, 2018 at 16:16 PM EDT
* APRICUS BIOSCIENCES SAYS ON APRIL 10, CO RECEIVED A NASDAQ STAFF DEFICIENCY LETTER - SEC FILING Source : https://bit.ly/2JMowAJ Further company coverage: (Reuters.Briefs@thomsonreuters.com)
